eResearch Technology Inc.  (ERES) Trade Now »     Rate ERES  -  Discuss ERES  -  Add to Watch List        

Filed under: Earnings reports, Analyst upgrades and downgrades, Technical Analysis, Stocks to Buy

eResearchTechnology (NASDAQ: ERES) provides technology and services to the pharmaceutical, biotechnology and medical device industries. The company streamlines the clinical trials process by enabling customers to automate the collection, analysis and distribution of data in all phases of clinical development. The firm's flagship product, EXPeRT, processes and interprets electrocardiogram data collected during trials, to insure cardiac safety. eResearchTechnology operates in the US and the UK.

The long-term investment thesis is really beginning to play out quite nicely for shares of eResearch Technology Inc. (ERES).<!--more--> The provider of cardiac safety services that evaluate the safety of new drugs has garnered record new bookings while increasing its share of the cardiac testing market, but it’s been a long time coming.